US5239062A
(en)
*
|
1986-03-20 |
1993-08-24 |
Dana-Farber Cancer Institute, Inc. |
Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity
|
US5395924A
(en)
*
|
1986-03-20 |
1995-03-07 |
Dana-Farber Cancer Institute, Inc. |
Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
|
US4997913A
(en)
*
|
1986-06-30 |
1991-03-05 |
Oncogen |
pH-sensitive immunoconjugates and methods for their use in tumor therapy
|
US4835258A
(en)
*
|
1986-12-24 |
1989-05-30 |
Northwestsern University |
Conjugation of aromatic amines or nitro-containing compounds with proteins or polypeptides by photoirradiation of the azide derivatives with ultraviolet light in order to produce antibodies against the haptens
|
US4952394A
(en)
*
|
1987-11-23 |
1990-08-28 |
Bristol-Myers Company |
Drug-monoclonal antibody conjugates
|
US5017693A
(en)
*
|
1987-12-02 |
1991-05-21 |
Neorx Corporation |
Methods for introducing a sulfhydryl amino or hydroxyl groups to a compound
|
US5141648A
(en)
*
|
1987-12-02 |
1992-08-25 |
Neorx Corporation |
Methods for isolating compounds using cleavable linker bound matrices
|
US5563250A
(en)
*
|
1987-12-02 |
1996-10-08 |
Neorx Corporation |
Cleavable conjugates for the delivery and release of agents in native form
|
US5171563A
(en)
*
|
1988-09-30 |
1992-12-15 |
Neorx Corporation |
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
|
JPH04502328A
(ja)
*
|
1988-12-05 |
1992-04-23 |
ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク |
シクロスポリンaの新規誘導体、それに対する抗体及びその使用
|
US5169635A
(en)
*
|
1989-11-17 |
1992-12-08 |
Fuji Photo Film Co., Ltd. |
Photoresponsive liposome
|
US5112953A
(en)
*
|
1989-12-29 |
1992-05-12 |
Neorx Corporation |
Radiolabeled proteins for diagnostic or therapeutic use
|
US5175257A
(en)
*
|
1989-12-29 |
1992-12-29 |
Neorx Corporation |
Radiolabeled proteins for diagnostic or therapeutic use
|
US5466681A
(en)
*
|
1990-02-23 |
1995-11-14 |
Microcarb, Inc. |
Receptor conjugates for targeting penicillin antibiotics to bacteria
|
US5650489A
(en)
*
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
AU665599B2
(en)
*
|
1991-11-08 |
1996-01-11 |
Hemosol Inc. |
Hemoglobins as drug delivery agents
|
DE69300409T2
(de)
*
|
1992-03-06 |
1996-02-01 |
Fiutowski Leszek |
Pharmazeutische Zusammensetzung mit antiviraler und antibakterieller Wirkung.
|
US5505931A
(en)
*
|
1993-03-04 |
1996-04-09 |
The Dow Chemical Company |
Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
|
US6313274B1
(en)
|
1992-07-06 |
2001-11-06 |
Thomas R. Sykes |
Photoactivation of proteins for conjugation purposes
|
US5382582A
(en)
*
|
1993-03-26 |
1995-01-17 |
Chan; Carcy L. |
Methotrexate analogs and methods of using same
|
AU7128494A
(en)
*
|
1993-07-09 |
1995-02-06 |
Celltech Limited |
Gelatinase antagonists used for treating cancer
|
US5470307A
(en)
*
|
1994-03-16 |
1995-11-28 |
Lindall; Arnold W. |
Catheter system for controllably releasing a therapeutic agent at a remote tissue site
|
WO1996023543A1
(en)
*
|
1995-01-30 |
1996-08-08 |
Angiomedics Ii Incorporated |
Photolytic drug delivery systems
|
US5698556A
(en)
*
|
1995-06-07 |
1997-12-16 |
Chan; Carcy L. |
Methotrexate analogs and methods of using same
|
ATE483733T1
(de)
|
1995-06-14 |
2010-10-15 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
JP3361932B2
(ja)
*
|
1996-05-29 |
2003-01-07 |
三菱電機株式会社 |
真空バルブ
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
JP2002507387A
(ja)
|
1997-12-24 |
2002-03-12 |
コリクサ コーポレイション |
乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
EP2003201A3
(de)
|
1998-03-18 |
2008-12-31 |
Corixa Corporation |
Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs
|
US6869604B1
(en)
*
|
1998-03-27 |
2005-03-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant anti-tumor RNAse
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
IL143531A0
(en)
|
1998-12-08 |
2002-04-21 |
Corixa Corp |
Polypeptides containing an antigenic portion of a chlamydia antigen, dna sequences encoding said polypeptides and pharmaceutical compositions and vaccines containing the same
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
GB9906192D0
(en)
|
1999-03-18 |
1999-05-12 |
Medical Res Council |
Photoreleasable compounds
|
MXPA01009962A
(es)
|
1999-04-02 |
2002-08-20 |
Corixa Corp |
Compuestos y metodos para terapia y diagnostico de cancer de pulmon.
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
AU2001266861A1
(en)
*
|
2000-06-12 |
2001-12-24 |
Randell L. Mills |
Photocleavable prodrugs for selective drug delivery
|
DE60134158D1
(de)
|
2000-06-28 |
2008-07-03 |
Corixa Corp |
Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
|
ATE425457T1
(de)
|
2000-10-06 |
2009-03-15 |
Life Technologies Corp |
Zellen mit spektraler signatur sowie verfahren zu ihrer herstellung und nutzung
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
JP2004528309A
(ja)
*
|
2001-03-23 |
2004-09-16 |
ナプロ バイオセラピューティクス,インコーポレイテッド |
癌治療用分子複合体
|
US7157458B2
(en)
|
2001-04-17 |
2007-01-02 |
Cryolife, Inc. |
Bifunctional energy-reversible acyl-compositions
|
EP1988097A1
(de)
|
2001-05-09 |
2008-11-05 |
Corixa Corporation |
Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Prostatakrebs
|
ES2405405T3
(es)
|
2001-12-17 |
2013-05-31 |
Corixa Corporation |
Composiciones y procedimientos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino
|
US20060099142A1
(en)
*
|
2002-03-14 |
2006-05-11 |
Delaney Allen D |
Cancer associated araf1 protein kinase and its uses
|
US6756397B2
(en)
|
2002-04-05 |
2004-06-29 |
Immunogen, Inc. |
Prodrugs of CC-1065 analogs
|
SI1530482T1
(sl)
|
2002-07-18 |
2014-03-31 |
Helix Biopharma Corp. |
Uporaba ureaze za inhibiranje rasti rakavih celic
|
US7390898B2
(en)
|
2002-08-02 |
2008-06-24 |
Immunogen Inc. |
Cytotoxic agents containing novel potent taxanes and their therapeutic use
|
EP1534340B1
(de)
|
2002-09-06 |
2011-11-16 |
Cerulean Pharma Inc. |
Polymere auf basis von cyclodextrin zur verabreichung von an diese kovalent gebundene arzneimittel
|
WO2004033638A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US7122361B2
(en)
*
|
2002-10-10 |
2006-10-17 |
Wyeth |
Compositions employing a novel human kinase
|
US20040096890A1
(en)
*
|
2002-10-10 |
2004-05-20 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US20050214292A1
(en)
*
|
2002-10-18 |
2005-09-29 |
Wyeth |
Compositions and methods for diagnosing and treating autoimmune disease
|
WO2004038026A2
(en)
*
|
2002-10-24 |
2004-05-06 |
Wyeth |
Calcineurin-like human phosphoesterase
|
US7611839B2
(en)
*
|
2002-11-21 |
2009-11-03 |
Wyeth |
Methods for diagnosing RCC and other solid tumors
|
AU2003290664A1
(en)
|
2002-11-27 |
2004-06-23 |
Wei Liu |
Compositions, organisms and methodologies employing a novel human kinase
|
DE602004015064D1
(de)
|
2003-01-06 |
2008-08-28 |
Wyeth Corp |
Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
|
WO2004070062A2
(en)
*
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
US20040191818A1
(en)
*
|
2003-02-26 |
2004-09-30 |
O'toole Margot Mary |
Compositions and methods for diagnosing and treating autoimmune diseases
|
JP2007537984A
(ja)
*
|
2003-03-04 |
2007-12-27 |
ワイス |
喘息または他のアレルギー性もしくは炎症性疾患の診断および治療のための組成物および方法
|
US20050043510A1
(en)
*
|
2003-04-10 |
2005-02-24 |
Moeckli Randolph A. |
Affinity purification system using troponin molecules as affinity ligands
|
WO2005001092A2
(en)
*
|
2003-05-20 |
2005-01-06 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
US20050027110A1
(en)
*
|
2003-07-24 |
2005-02-03 |
Michael Russell |
Drug delivery in the nervous system
|
US8071652B2
(en)
*
|
2003-08-21 |
2011-12-06 |
The Board Of Regents Of The University Of Texas System |
Method of treating irritable bowel syndrome
|
AU2005265163B2
(en)
|
2004-06-18 |
2009-10-01 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
WO2006031614A2
(en)
*
|
2004-09-10 |
2006-03-23 |
Tosk, Inc. |
Reduced toxicity methotrexate formulations and methods for using the same
|
ES2371203T3
(es)
*
|
2005-06-07 |
2011-12-28 |
Centre National De La Recherche Scientifique (Cnrs) |
Utilización de conjugados con conectores cortables mediante fotodisociación o fragmentación para el análisis de espectrometría de masas de las secciones de tejido.
|
WO2007051077A2
(en)
*
|
2005-10-28 |
2007-05-03 |
The Regents Of The University Of California |
Methods and compounds for lymphoma cell detection and isolation
|
NZ568288A
(en)
|
2005-11-28 |
2012-02-24 |
Verrow Pharmaceuticals Inc |
Compositions comprising a a cyclodextrin and a nephrotoxic anticancer drug
|
PL1813614T3
(pl)
|
2006-01-25 |
2012-03-30 |
Sanofi Sa |
Środki cytotoksyczne zawierające nowe pochodne tomaymycyny
|
CA2648718A1
(en)
|
2006-04-07 |
2007-10-18 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
US9044461B2
(en)
|
2006-04-07 |
2015-06-02 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
EP1864682A1
(de)
|
2006-06-09 |
2007-12-12 |
Sanofi-Aventis |
Leptomycinderivate
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
WO2008124768A1
(en)
|
2007-04-09 |
2008-10-16 |
The General Hospital Corporation |
Hemojuvelin fusion proteins and uses thereof
|
WO2009039192A2
(en)
|
2007-09-17 |
2009-03-26 |
The Regents Of The University Of Californina |
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
|
WO2009067546A2
(en)
|
2007-11-19 |
2009-05-28 |
Celera Corpration |
Lung cancer markers and uses thereof
|
AU2009223453B2
(en)
|
2008-03-03 |
2014-05-01 |
Tosk, Inc. |
Methotrexate adjuvants to reduce toxicity and methods for using the same
|
JP5756751B2
(ja)
|
2008-06-26 |
2015-07-29 |
エータイアー ファーマ, インコーポレイテッド |
非正準的な生物学的活性を有するグリシル−tRNA合成酵素を含む組成物および方法
|
EP2403864B1
(de)
|
2009-02-27 |
2015-08-12 |
Atyr Pharma, Inc. |
Polypeptidstrukturmotive im zusammenhang mit zellsignalisierungsaktivität
|
CA2755784C
(en)
|
2009-03-16 |
2020-03-24 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
|
WO2010120509A2
(en)
|
2009-03-31 |
2010-10-21 |
Atyr Pharma, Inc. |
Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
|
CA2795906C
(en)
|
2009-04-13 |
2019-02-26 |
Inserm, Institut National De La Sante Et De La Recherche Medicale |
Hpv particles and uses thereof
|
CA3057650A1
(en)
|
2009-09-15 |
2011-03-24 |
Irving L. Weissman |
Synergistic anti-cd47 therapy for hematologic cancers
|
CN107261150A
(zh)
*
|
2009-11-23 |
2017-10-20 |
布鲁林克医药品公司 |
用于传递治疗剂的基于环糊精的聚合物
|
CN106474462A
(zh)
|
2009-12-11 |
2017-03-08 |
Atyr 医药公司 |
用于调节炎症的氨酰tRNA合成酶
|
US20130177555A1
(en)
|
2010-08-13 |
2013-07-11 |
Medimmune Limited |
Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use
|
AU2011336467A1
(en)
|
2010-12-01 |
2013-07-04 |
Spinal Modulation, Inc. |
Agent delivery systems for selective neuromodulation
|
EP2683740B1
(de)
|
2011-03-10 |
2018-07-04 |
Omeros Corporation |
Erzeugung monoklonaler anti-fn14-antikörper durch ex-vivo beschleunigte antikörperentwicklung
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
BR112014002219A2
(pt)
|
2011-07-05 |
2018-08-07 |
Bioasis Technologies Inc |
conjugados anticorpo p97 e métodos de sua utilização
|
US9120858B2
(en)
|
2011-07-22 |
2015-09-01 |
The Research Foundation Of State University Of New York |
Antibodies to the B12-transcobalamin receptor
|
JP5944994B2
(ja)
|
2011-08-12 |
2016-07-05 |
オメロス コーポレーション |
抗fzd10モノクローナル抗体およびそれらの使用方法
|
WO2013119877A1
(en)
|
2012-02-07 |
2013-08-15 |
Aura Biosciences, Inc. |
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
|
HUE043552T2
(hu)
|
2012-06-08 |
2019-09-30 |
Sutro Biopharma Inc |
Antitestek, amelyek tartalmaznak helyspecifikus nem természetes aminosav maradékokat, eljárások elõállításukra és eljárások használatukra
|
EP3369747A1
(de)
|
2012-06-25 |
2018-09-05 |
The Brigham and Women's Hospital, Inc. |
Gezielte therapeutika
|
EP2863955B1
(de)
|
2012-06-26 |
2016-11-23 |
Sutro Biopharma, Inc. |
Modifizierte fc-proteine mit nichtnatürlichen ortsspezifische aminosäureresten, konjugate daraus, verfahren zu deren herstellung und verfahren zu deren verwendung
|
US9932565B2
(en)
|
2012-07-31 |
2018-04-03 |
Bioasis Technologies, Inc. |
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
|
AU2013296494B2
(en)
|
2012-08-02 |
2018-04-26 |
Stealth Biotherapeutics Inc. |
Methods for treatment of atherosclerosis
|
BR112015004022B1
(pt)
|
2012-08-31 |
2023-04-25 |
Sutro Biopharma, Inc |
Aminoácidos modificados compreendendo um grupo azido
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
WO2014164981A1
(en)
|
2013-03-12 |
2014-10-09 |
The General Hospital Corporation |
Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
|
EP2970433B1
(de)
|
2013-03-13 |
2019-09-18 |
Bioasis Technologies Inc. |
Fragmente von p97 und verwendungen davon
|
EP3019522B1
(de)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Antikörper mit mehreren ortsspezifischen nichtnatürlichen aminosäureresten, verfahren zu deren herstellung und verfahren zu deren verwendung
|
AU2014312190A1
(en)
|
2013-08-28 |
2016-02-18 |
Bioasis Technologies Inc. |
CNS-targeted conjugates of antibodies
|
ES2729841T3
(es)
|
2013-09-18 |
2019-11-06 |
Aura Biosciences Inc |
Conjugados de partículas similares a virus para tratar tumores
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
CA2933335A1
(en)
|
2013-12-11 |
2015-06-18 |
The General Hospital Corporation |
Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
|
ES2728668T3
(es)
|
2014-01-08 |
2019-10-28 |
Univ Leland Stanford Junior |
Terapia dirigida para el cáncer de pulmón de células pequeñas
|
WO2015112904A1
(en)
|
2014-01-24 |
2015-07-30 |
University Of Florida Research Foundation, Inc. |
Socs mimetics for the treatment of diseases
|
CA2950410A1
(en)
|
2014-05-28 |
2015-12-03 |
D. Travis Wilson |
Therapeutic compositions including therapeutic small molecules and uses thereof
|
EP3501532A3
(de)
|
2014-05-28 |
2019-07-17 |
Stealth BioTherapeutics Corp |
Therapeutische zusammensetzungen mit frataxin, lactoferrin, sowie mitochondrialen energieerzeugungsenzymen und verwendungen davon
|
CA2944085C
(en)
|
2014-09-16 |
2018-04-10 |
Ease Charm Limited |
Anti-egfr antibody and uses of same
|
WO2016141230A1
(en)
|
2015-03-05 |
2016-09-09 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
JP7044373B2
(ja)
|
2015-07-15 |
2022-03-30 |
ラトガース,ザ ステート ユニバーシティ オブ ニュージャージー |
ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途
|
WO2017011826A1
(en)
|
2015-07-16 |
2017-01-19 |
Case Western Reserve University |
Plant virus particles for delivery of antimitotic agents
|
WO2017075440A1
(en)
|
2015-10-30 |
2017-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Targeted cancer therapy
|
CA3002573A1
(en)
|
2015-11-03 |
2017-05-11 |
Ambrx, Inc. |
Anti-cd3 antibodies and their uses
|
WO2017095823A1
(en)
|
2015-11-30 |
2017-06-08 |
The Regents Of The University Of California |
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
|
JP7306827B2
(ja)
|
2016-01-27 |
2023-07-11 |
ストロ バイオファーマ インコーポレーテッド |
抗cd74抗体コンジュゲート、抗cd74抗体コンジュゲートを含む組成物および抗cd74抗体コンジュゲートを使用する方法
|
WO2018045245A1
(en)
|
2016-09-02 |
2018-03-08 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
WO2018089829A1
(en)
|
2016-11-10 |
2018-05-17 |
Fortis Therapeutics, Inc. |
Cd46-specific effector cells and uses thereof
|
US11434301B2
(en)
|
2016-11-11 |
2022-09-06 |
The Regents Of The University Of California |
Anti-CD46 antibodies and methods of use
|
EP3551766B1
(de)
|
2016-12-12 |
2022-09-14 |
Cepheid |
Integrierte immuno-pcr und nukleinsäureanalyse in einer automatisierten reaktionskartusche
|
US20190330658A1
(en)
|
2017-01-05 |
2019-10-31 |
Rutgers, The State University |
Targeted gene editing platform independent of dna double strand break and uses thereof
|
US20200207859A1
(en)
|
2017-07-26 |
2020-07-02 |
Sutro Biopharma, Inc. |
Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma
|
US11078217B2
(en)
*
|
2017-09-05 |
2021-08-03 |
University Of Massachusetts |
Triplet-triplet annihilation upconversion system, and compositions and methods thereof for drug delivery
|
WO2019055931A1
(en)
|
2017-09-18 |
2019-03-21 |
Sutro Biopharma, Inc. |
ALPHA ANTI-FOLATE ANTIBODY-RECEPTOR CONJUGATES AND USES THEREOF
|
CN111902158A
(zh)
|
2018-03-22 |
2020-11-06 |
儿童医疗中心有限公司 |
与肺修复有关的方法和组合物
|
US20220162336A1
(en)
|
2018-07-22 |
2022-05-26 |
Bioasis Technologies, Inc. |
Treatment of lymphatic metastases
|
JP2021535140A
(ja)
|
2018-08-28 |
2021-12-16 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
抗cd3抗体葉酸生物複合体およびその使用
|
WO2020060944A1
(en)
|
2018-09-17 |
2020-03-26 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
CA3128081A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
WO2020227105A1
(en)
|
2019-05-03 |
2020-11-12 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
CN114269749A
(zh)
|
2019-06-10 |
2022-04-01 |
苏特罗生物制药公司 |
5H-吡咯并[3,2-d]嘧啶-2,4-二氨基化合物及其抗体偶联物
|
WO2020257235A1
(en)
|
2019-06-17 |
2020-12-24 |
Sutro Biopharma, Inc. |
1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis
|
WO2021173889A1
(en)
|
2020-02-26 |
2021-09-02 |
Ambrx, Inc. |
Uses of anti-cd3 antibody folate bioconjugates
|
US20210355468A1
(en)
|
2020-05-18 |
2021-11-18 |
Bioasis Technologies, Inc. |
Compositions and methods for treating lewy body dementia
|
US20210393787A1
(en)
|
2020-06-17 |
2021-12-23 |
Bioasis Technologies, Inc. |
Compositions and methods for treating frontotemporal dementia
|
EP4179079A1
(de)
|
2020-07-10 |
2023-05-17 |
Horizon Discovery Limited |
Verfahren zur herstellung genetisch modifizierter zellen
|
US11484604B2
(en)
|
2020-08-07 |
2022-11-01 |
Fortis Therapeutics, Inc. |
Immunoconjugates targeting CD46 and methods of use thereof
|
US20230302150A1
(en)
|
2020-08-20 |
2023-09-28 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
WO2022103983A2
(en)
|
2020-11-11 |
2022-05-19 |
Sutro Biopharma, Inc. |
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
|
CA3207144A1
(en)
|
2021-01-05 |
2022-07-14 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
WO2022212899A1
(en)
|
2021-04-03 |
2022-10-06 |
Ambrx, Inc. |
Anti-her2 antibody-drug conjugates and uses thereof
|
KR20240004659A
(ko)
|
2021-04-30 |
2024-01-11 |
셀진 코포레이션 |
감마 세크레타제 억제제(gsi)와 병용하여 항-bcma 항체-약물 접합체(adc)를 사용하는 병용 요법
|
TW202408589A
(zh)
|
2022-06-30 |
2024-03-01 |
美商舒卓生物製藥公司 |
抗ror1抗體及抗體結合物、包含抗ror1抗體或抗體結合物之組合物,及製造及使用抗ror1抗體及抗體結合物之方法
|